• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthIllness
Europe

Mystery of global uptick in hepatitis affecting children may have been solved

By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
July 26, 2022, 7:37 AM ET
Adenoviruses, a common seasonal infection, have been identified as one possible cause of the global surge in unexplained childhood hepatitis.
Adenoviruses, a common seasonal infection, have been identified as one possible cause of the global surge in unexplained childhood hepatitis. BSIP/UIG/Getty Images

Scientists believe they have found the root cause of the mysterious cases of childhood hepatitis that have swept across the globe—and it isn’t COVID-19.

Since April, doctors across the globe have been puzzled by hundreds of cases of young children developing jaundice and unexplained severe hepatitis.

Hepatitis, or liver inflammation, can be a viral infection, but the common viruses associated with acute viral hepatitis — hepatitis A, B, C, D, and E— were not identified among the children being hospitalized with the condition.

As of July 8, 35 countries had reported a collective 1,010 probable cases of severe acute hepatitis with an unknown cause to the WHO.

75% of cases in Europe had been in children under the age of 5, as of May 20, with a total of 12% of the children whose records were analyzed receiving a liver transplant.

Since the outbreak was detected on April 5, there have been 22 deaths attributed to the phenomenon, according to WHO data.  

What’s the cause?

The outbreak has perplexed experts who, so far, have struggled to find a common denominator among the children suffering from the condition.

Theories about what’s causing the eruption in cases have ranged from COVID-19 to pets, with the WHO saying earlier this month that human-to-human transmission “cannot be ruled out following a few early reports of epidemiologically linked cases.”

Scientists, meanwhile, have pointed the finger at a common seasonal virus (adenoviruses) that usually causes mild colds but can cause various symptoms including fever, pink eye and stomach bugs.  

Some medical experts have theorized that COVID restrictions suppressed immunity to bugs like adenoviruses by stopping their circulation within the population, with adenovirus infections rebounding in the U.K. as lockdowns were lifted.

‘The best explanation’

British scientists said on Monday that their research has shown that co-infection with two common viruses may offer “the best explanation” for the onset of severe liver disease in affected children.

Findings from two separate studies suggested that the key was adeno-associated virus 2 (AAV2), a pathogen that does not normally cause disease in itself but often accompanies infection with adenoviruses.

The studies, carried out by teams in Scotland and London, examined blood samples from children with acute hepatitis, as well as liver samples from children who had extremely severe cases that required liver transplants.

AAV2, which cannot replicate inside the human body without a “helper” virus, was found in 96% of cases of unexplained hepatitis across both studies.

The virus, a member of the parovirus family, was found in the blood and liver of patients included in the studies, and was found to be replicating in the liver.

In control groups—made up of children who did not have acute hepatitis—AAV2 was either absent or present in very low levels.

Researchers concluded that being simultaneously infected with AAV2 and either an adenovirus or, less commonly, the herpes virus HHV6, was likely to be behind the outbreak in acute pediatric hepatitis.

HHV6 is the collective term for the closely related viruses HHV-6A and HHV-6B, which can cause an illness called Roseola that leads to symptoms including a rash, fever and swollen glands.

Close to 100% of human beings are thought to be infected with HHV6, which is different to the strain of the virus that causes cold sores or genital herpes.

Emma Thomson, clinical professor and consultant in infectious diseases at the MRC-University of Glasgow Centre for Virus Research and senior author of the Scottish study, said on Monday that AAV2 may be the cause of the hepatitis itself, or it may be a biomarker of recent adenovirus which could be the main underlying pathogen.

“There are many unanswered questions and larger studies are urgently needed to investigate the role of AAV2 in pediatric hepatitis cases,” she said.

“We also need to understand more about seasonal circulation of AAV2, a virus that is not routinely monitored—it may be that a peak of adenovirus infection has coincided with a peak in AAV2 exposure, leading to an unusual manifestation of hepatitis in susceptible young children.”

Meanwhile, Judy Breuer a professor of virology at UCL Great Ormond Street Institute of Child Health, stressed that while unanswered questions remained around the spike in childhood hepatitis, neither of the research teams found a direct link between the cases and COVID-19.

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Chloe Taylor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Best protein lead image
HealthDietary Supplements
The 9 Best Protein Powders of 2026: How to Choose, According to an RD
By Christina SnyderJanuary 14, 2026
2 hours ago
Gates
PoliticsGates Foundation
One year after Bill Gates surprised with the choice to close his foundation by 2045, he’s cutting staff jobs
By Stephanie Beasley and The Associated PressJanuary 14, 2026
2 hours ago
Best Outdoor Saunas
Healthoutdoor and sporting goods
The Best Outdoor Saunas of 2026: Tested and Reviewed
By Christina SnyderJanuary 14, 2026
10 hours ago
Healthchief executive officer (CEO)
Elon Musk says humans are ‘pre-programmed to die’ and longevity is ‘solvable’, raising huge questions about the future of health
By Marco Quiroz-GutierrezJanuary 14, 2026
14 hours ago
hybrid
Future of Workhybrid
‘Hybrid creep’ is the latest trick bosses are using to get workers back in the office
By Nick LichtenbergJanuary 13, 2026
1 day ago
Successthe future of work
Elon Musk shares 4 bold predictions for the future of work: Robot surgeons in 3 years, immortality, and no need for retirement savings
By Orianna Rosa RoyleJanuary 13, 2026
1 day ago

Most Popular

placeholder alt text
Success
Despite his $2.6 billion net worth, MrBeast says he’s having to borrow cash and doesn’t even have enough money in his bank account to buy McDonald’s
By Emma BurleighJanuary 13, 2026
1 day ago
placeholder alt text
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the capitalist system'
By Jason MaJanuary 12, 2026
2 days ago
placeholder alt text
Future of Work
'Microshifting,' an extreme form of hybrid working that breaks work into short, non-continuous blocks, is on the rise
By Nick LichtenbergJanuary 13, 2026
1 day ago
placeholder alt text
Economy
Goldman Sachs top economist says Powell probe won’t change the Fed: 'Decisions are going to be made based on employment and inflation'
By Sasha RogelbergJanuary 12, 2026
2 days ago
placeholder alt text
Economy
Americans making more than $100,000 are quickly losing faith in the economy—and it's a red flag for the white-collar job market
By Tristan BoveJanuary 12, 2026
2 days ago
placeholder alt text
Economy
The longer the Supreme Court delays its tariff decision, the better it is for President Trump
By Jim EdwardsJanuary 13, 2026
2 days ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.